Rezultati - Fennelly, D.
- Showing 1 - 4 results of 4
-
1
-
2
Tumour microenvironment of both early- and late-stage colorectal cancer is equally immunosuppressive od O'Toole, A, Michielsen, A J, Nolan, B, Tosetto, M, Sheahan, K, Mulcahy, H E, Winter, D C, Hyland, J M, O'Connell, P R, Fennelly, D, O'Donoghue, D, O'Sullivan, J, Doherty, G A, Ryan, E J
Izdano 2014Text -
3
Effects of CDX2 on prognosis and chemotherapy responsiveness in mismatch repair‐deficient colorectal cancer od Ryan, É. J., Creavin, B., Khaw, Y. L., Kelly, M. E., Mohan, H. M., Geraghty, R., Ryan, E. J., Kennelly, R., Hanly, A., Martin, S. T., Fennelly, D., McDermott, R., Gibbons, D., O'Connell, P. R, Sheahan, K., Winter, D. C.
Izdano 2018Text -
4
A randomised phase II multicentre trial of irinotecan (CPT-11) using four different schedules in patients with metastatic colorectal cancer od Schoemaker, N E, Kuppens, I E L M, Moiseyenko, V, Glimelius, B, Kjaer, M, Starkhammer, H, Richel, D J, Smaaland, R, Bertelsen, K, Poulsen, J P, Voznyi, E, Norum, J, Fennelly, D, Tveit, K M, Garin, A, Gruia, G, Mourier, A, Sibaud, D, Lefebvre, P, Beijnen, J H, Schellens, J H M, ten Bokkel Huinink, W W
Izdano 2004Text